Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 5, 2004 - Issue 7
Submit an article Journal homepage
291
Views
7
CrossRef citations to date
0
Altmetric
Drug Evaluation

Alprazolam extended-release in panic disorder

Karl Rickels University of Pennsylvania, Department of Psychiatry, University of Pennsylvania Medical Center, PA 19104-3309, USA. [email protected]
Pages 1599-1611 | Published online: 25 Feb 2005

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Lizheng Shi, Meredith Hodges, Nicole Yurgin & Kristina S Boye. (2007) Impact of dose frequency on compliance and health outcomes: a literature review (1966–2006). Expert Review of Pharmacoeconomics & Outcomes Research 7:2, pages 187-202.
Read now
Malcolm Lader. (2005) Management of panic disorder. Expert Review of Neurotherapeutics 5:2, pages 259-266.
Read now

Articles from other publishers (5)

Paul M. Burkat. (2023) Physiologically based pharmacokinetic and pharmacodynamic modelling of alprazolam: Implications for anxiety and addiction. British Journal of Clinical Pharmacology 89:8, pages 2569-2581.
Crossref
Alan F. Schatzberg & Charles DeBattista. 2019. Schatzberg’s Manual of Psychopharmacology. Schatzberg’s Manual of Psychopharmacology.
Alan F. Schatzberg & Charles DeBattista. 2019. Schatzberg’s Manual of Psychopharmacology. Schatzberg’s Manual of Psychopharmacology.
Tatiana Paschoalin-Maurin, Tayllon dos Anjos-Garcia, Luiz Luciano Falconi-Sobrinho, Renato Leonardo de Freitas, Jade Pissamiglio Cysne Coimbra, Carlos Júlio Laure & Norberto Cysne Coimbra. (2018) The Rodent-versus-wild Snake Paradigm as a Model for Studying Anxiety- and Panic-like Behaviors: Face, Construct and Predictive Validities. Neuroscience 369, pages 336-349.
Crossref
Tim R. M. Leufkens, Annemiek Vermeeren, Beitske E. Smink, Peter van Ruitenbeek & Johannes G. Ramaekers. (2007) Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg. Psychopharmacology 191:4, pages 951-959.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.